The study, supported by MindMaze Therapeutics, builds on findings recently published in Nature Medicine. Those results demonstrated that electrical stimulation of the spinal cord could provide immediate, short-term improvements in hand and arm function for patients with chronic stroke. The new clinical trial, currently enrolling 20 participants, aims to determine if combining this stimulation with a high volume of intent-driven practice can cement these improvements into long-term recovery.
In section Releases
MindMaze and University of Pittsburgh Test Combo Therapy for Stroke
Researchers at the University of Pittsburgh have begun a clinical trial testing whether pairing cervical spinal cord stimulation with high-intensity neurotherapy can produce lasting improvements in arm movement for stroke survivors, moving beyond the temporary assistive gains seen in earlier studies.
Participants will undergo a six-week training course before receiving an implantable stimulation system. Following the procedure, they will repeat the training regimen with active stimulation to test the durability of motor gains over a six-month follow-up period. MindMaze Therapeutics’ platform is designed to provide the necessary intensity of practice without increasing clinical staffing requirements, a core challenge in current stroke rehabilitation. CEO Zach Henderson stated that the company is focused on positioning its technology at the frontier of combination therapies to assist patients who have reached a plateau with conventional treatment.
Comments (0)
No comments yet. Be the first!